A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment.
about
Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and ManagementA psychological intervention to promote acceptance and adherence to non-invasive ventilation in people with chronic obstructive pulmonary disease: study protocol of a randomised controlled trialOffice-based simple frailty score and central blood pressure predict mild cognitive impairment in an apparently healthy Japanese population: J-SHIPP study.Oxygen therapy for COPD.Lung disease as a determinant of cognitive decline and dementia.Comparison of clinical characteristics and outcomes between aspiration pneumonia and community-acquired pneumonia in patients with chronic obstructive pulmonary disease.Chronic Obstructive Pulmonary Disease as a Risk Factor for Cognitive Dysfunction: A Meta-Analysis of Current Studies.Multimorbidity and Risk of Mild Cognitive Impairment.Increased Risk of Dementia in Patients With Chronic Obstructive Pulmonary Disease.Association of Chronic Obstructive Pulmonary Disease With Increased Confusion or Memory Loss and Functional Limitations Among Adults in 21 States, 2011 Behavioral Risk Factor Surveillance System.Brain health: the importance of recognizing cognitive impairment: an IAGG consensus conferenceMultimorbidity and neuroimaging biomarkers among cognitively normal personsResistance of subventricular neural stem cells to chronic hypoxemia despite structural disorganization of the germinal center and impairment of neuronal and oligodendrocyte survivalDesensitisation to cigarette package graphic health warnings: a cohort comparison between London and Singapore.Electrophysiological assessment in patients with long term hypoxia.Recognition, diagnosis, and treatment of cognitive and psychiatric disorders in patients with COPD.Prevalence of mild cognitive impairment in employable patients after acute coronary event in cardiac rehabilitation.Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus.The association between chronic obstructive pulmonary disease and dementia: a population-based retrospective cohort study.Cognitive impairment and risk for disability in chronic obstructive pulmonary disease.Individualizing the selection of long-acting bronchodilator therapy for patients with COPD: considerations in primary care.Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.Serum Amyloid-Beta Levels are Increased in Patients with Chronic Obstructive Pulmonary Disease.Midlife and Late-Life Smoking and Risk of Dementia in the Community: The Hisayama Study.Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Possible Utility of Marine Bioactive Compounds
P2860
Q26799659-2BBE1688-6376-44EA-8B46-355C2076C240Q29247950-3109413D-BCDE-42E6-A269-C681E49E58FBQ33560051-3E6E882D-B476-4D79-AB27-D5C16755CF9DQ34628625-7C7D600F-93AA-4F68-98FC-08E36172E40CQ35204219-CC4FADF4-F275-41B9-9FBF-B35C053BBAA0Q35685421-16EA5216-BAAC-4734-BA42-26F350E16DB1Q35953789-E0740DA9-FEEC-4179-8962-8BDA9FA95CEFQ36165338-99BDB667-9CBD-4A7E-A725-44A87D3C5294Q36194290-C3B544CA-FE3D-490F-B88D-3B5914280EF2Q36450277-4DA7299B-CFD3-446F-948A-9F39F9ADC120Q36770136-A59BBAF8-3F3A-4B2B-A1C8-C884B2066B7FQ36963306-49F948D0-A7C9-40D4-BCF2-D2DD889E414EQ37301044-34DE5AF2-861B-4364-86DD-77704F64C8FEQ37390333-0CBCF710-1856-4104-A387-4AA71F15C705Q37577279-828A9900-8C1C-4FCE-B492-56A627F8CB1FQ37652871-618C7187-15E1-4994-80D6-60FE31193820Q37669360-3A6E3281-480B-430E-9622-E6E6EC2FCBC1Q41441617-64482FFC-4DA5-4DAF-85AB-9A6C54128DC5Q46535026-55AE6193-6071-402B-9152-159806BBD399Q46631732-83D43BD9-AE61-47B0-8C47-98717734B31DQ47710084-1BBB5513-A1AB-464D-BCAB-727CF459DDFEQ50563391-0D8B0B6F-3035-4525-A3D2-07B3AF6AD2ABQ51606665-E3402C8D-F396-4C2B-A19D-7CFA33E0C633Q53369576-170D0222-2B3F-43B7-936A-D7D52DDB6967Q58764243-337B15DD-17BD-4E8B-A270-AAA5A4B3B682
P2860
A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A prospective study of chronic ...... for mild cognitive impairment.
@ast
A prospective study of chronic ...... for mild cognitive impairment.
@en
type
label
A prospective study of chronic ...... for mild cognitive impairment.
@ast
A prospective study of chronic ...... for mild cognitive impairment.
@en
prefLabel
A prospective study of chronic ...... for mild cognitive impairment.
@ast
A prospective study of chronic ...... for mild cognitive impairment.
@en
P2093
P2860
P1433
P1476
A prospective study of chronic ...... for mild cognitive impairment.
@en
P2093
Ajay K Parsaik
Paul D Scanlon
Ronald C Petersen
Rosebud O Roberts
Ruth H Cha
Teresa J Christianson
V Shane Pankratz
Yonas E Geda
P2860
P304
P356
10.1001/JAMANEUROL.2014.94
P407
P577
2014-05-01T00:00:00Z